台灣臨床試驗主持人資料庫|TPIDB

問卷

Log In

繁中 EN

TPIDB

TPIDB Outstanding PI

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberD1690C00023

2015-08-01 - 2017-09-30

Phase III

Terminated7

ICD-10E11.21

Type 2 diabetes mellitus with diabetic nephropathy

ICD-10E11.22

Type 2 diabetes mellitus with diabetic chronic kidney disease

ICD-10E11.29

Type 2 diabetes mellitus with other diabetic kidney complication

ICD-10E13.21

Other specified diabetes mellitus with diabetic nephropathy

ICD-10E13.22

Other specified diabetes mellitus with diabetic chronic kidney disease

ICD-10E13.29

Other specified diabetes mellitus with other diabetic kidney complication

ICD-9250.40

Diabetes with renal manifestations, Type II [non-insulin dependent type][NIDDM type][adult-onset type] or unspecified type ,not stated as uncontrolled

Trial Applicant
Sponsor
Trial scale

Multi-Regional Multi-Center
Update

2025/08/20

Investigators and Locations

Principal Investigator 許惠恒 Division of Endocrinology

Taichung Veterans General Hospital

Co-Principal Investigator

I-TE LEE Division of Endocrinology
李佳霖 Division of Endocrinology
李宇璇 Division of Endocrinology
JUN-SING WANG Division of Endocrinology
李昂澤 Division of Endocrinology
CHENG-HSU CHEN Division of Nephrology
林時逸 Division of Endocrinology
蔡易婷 Division of Endocrinology
蔡尚峰 Division of Nephrology
傅家保 Division of Endocrinology
陳昱瑋 Division of Endocrinology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 田凱仁 Division of Endocrinology

Chi Mei Medical Center

Co-Principal Investigator

楊純宜 Division of Endocrinology
李尚育 Division of Endocrinology
葉乃誠 Division of Endocrinology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 陳榮福 Division of Endocrinology

Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.

Co-Principal Investigator

董石城 Division of Endocrinology
張智閔 Division of Endocrinology
郭銘俊 Division of Endocrinology
沈峰志 Division of Endocrinology
蔡嘉仁 Division of Endocrinology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 杜思德 Division of Endocrinology

CHANGHUA CHRISTIAN HOSPITAL

Co-Principal Investigator

王舒儀 Division of Endocrinology
邱炳芳 Division of Nephrology
郭仁富 Division of Endocrinology
許上人 Division of Endocrinology
林世鐸 Division of Endocrinology
楊郁 Division of Nephrology
鄭畬方 Division of Endocrinology
蘇矢立 Division of Endocrinology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 裴馰 Division of Endocrinology

Cardinal Tien Hospital

Co-Principal Investigator

夏德霖 Division of Endocrinology
鍾明敏 Division of Endocrinology
馬文雅 Division of Endocrinology
蘇景傑 Division of Endocrinology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Wen-Chung Yu Division of Cardiovascular Diseases

Taipei Veterans General Hospital

Co-Principal Investigator

Chern-En Chiang 醫研部新藥臨床試驗中心主任
Chin-Sung Kuo Division of Endocrinology
李慶威醫務企管部主治醫師
Shih-Hsien Sung Division of Cardiovascular Diseases
廖若男 Division of Cardiovascular Diseases
Tse-Min Lu 健康管理中心實驗檢查科主任
林怡君 Division of Endocrinology
Kang-Ling Wang 醫研部主治醫師
許百豐 Division of Family Medicine

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 江珠影 Division of Endocrinology

Far Eastern Memorial Hospital

Co-Principal Investigator

林蓉 Division of Endocrinology
陳華芬 Division of Endocrinology
黃聖煒 Division of Endocrinology
李明蒼 Division of Endocrinology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

Taiwan

40 participants
Global

450 participants